Global Healthcare Intelligence/Markets/Regulatory Navigator/Global
← Egypt intelligence
NEW / UPDATEDLast verified 2026-10-07

Violative advertisements list — Egypt

Country
Egypt
Official organization
Egyptian Drug Authority (EDA)
Category
compliance watch
Product / sector
Pharmaceuticals · Medical Devices & IVDs · Cosmetics
Publication / issue date
2026-09-02
Document version
Not specified
Official source
Egyptian Drug Authority Launches the “Violative Advertisements” List

OFFICIAL SOURCE FACTS / REQUIREMENT FRAMEWORK

What you need to know

  • EDA launched its advertising-violations list on 2 September 2026.
  • EDA describes unauthorized promotion for registered products and misleading promotion of unregistered products among the identified cases. No individual violation list is reproduced here.

What changed

EDA launched the official list on 2 September 2026.

This summary is not a complete regulatory checklist. Applicability, conditions and exclusions remain governed by the original official document.

Who is affected

  • Marketing
  • Regulatory Affairs
  • Compliance
  • Manufacturers
  • Importers
  • Product owners

PHARMA GATE INTERPRETATION — NOT AN OFFICIAL REQUIREMENT

Pharma Gate Intelligence

Use the current official list as an input to professional review; do not treat unofficial copies as authoritative or infer a violation from this brief.

Business impact

Advertising and claims review should be coordinated with regulatory compliance.

RECOMMENDED ACTION — NOT A REGULATORY DETERMINATION

What to check

  • Current official list
  • Product registration and relevant advertising authorization
  • Claims and promotional materials under review

Recommended next step

Have regulatory and compliance teams review applicable promotional materials against official sources.

  1. Product / claims
  2. Official source
  3. Compliance assessment
  4. Professional support

NEXT STEP

Need help navigating this requirement?

Pharma Gate is not a regulatory authority. Professional providers are independent organizations subject to platform review.

VERIFIED SOURCE GOVERNANCE

Official facts are attributed to issuing authorities. Pharma Gate analysis and recommended actions are clearly separated.

How we verify intelligence

Official facts are attributed to the issuing organization. Pharma Gate interpretation and recommended actions are separate editorial layers, not legal requirements or regulatory approval. Sources are prioritized: national regulators, WHO and recognized intergovernmental bodies, official procurement organizations, then other official governmental or institutional sources.

Publication records retain source title, version, issue date, verification date, country, sector and status. Draft / Public Consultation is distinct from Current. Superseded and Archived records do not represent current requirements. A verification date records the review performed; it is not an assurance of continuous monitoring. Always check the latest official source before acting.